Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (21541)	5/29/1998 7:17:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Reuter's also carried the NDA news: Wednesday May 27, 9:34 pm Eastern Time Ligand applies for Panretin approval SAN DIEGO, May 27 (Reuters) - Ligand Pharmaceuticals Inc on Wednesday said it has submitted its first new drug application to the U.S. Food and Drug Administration for Panretin gel, or alitretinoin, used to help treat patients with AIDS-related Kaposi's sarcoma. If approved, Panretin gel would provide the first topical therapy for Kaposi's Sarcoma, a cancer common in people who have AIDS, the company said in a statement.

To: Hippieslayer who wrote (21541)	5/29/1998 8:01:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Here's more LGND related news: May 28) BUSINESS WIRE - WHO: Education, Healthcare, Business and Community Feature Reporters WHAT: BIOCOM/San Diego's Breakfast Meeting "Workforce Development: Catching Up To Industry Growth" Panel Alan D. Bersin, Superintendent-Designee San Diego Unified School District Edward A. Dennis, Ph.D., UCSD Chair, Industrial Advisory Board and Professor, Chemistry & Biochemistry Chancellor Augie Gallego, San Diego Community College District Ethan Singer, Interim VP Academic Affairs SDSU Moderator: David Robinson, Chairman, President & CEO, Ligand Pharmaceuticals and 1998 BIOCOM President WHERE: Sheraton Grande Torrey Pines 10950 North Torrey Pines Road, La Jolla WHEN: 7:30 - 9:00 a.m. Wednesday, June 10, 1998 WHY: How to grow a skilled, well-educated homegrown workforce for the healthcare technology industry will be the focus of this BIOCOM breakfast. Each panelist will discuss his institution's current academia in biosciences, vision for future partnerships with industry, and collaborative efforts with other educational organizations. This is another highly significant issue in the area of higher education. Hear from the experts on this hot issue! If you wish a direct interview, we will do our best to accommodate your request. MEDIA: Contact Marcelle Vogel, BIOCOM at 619/455-0300 For more BIOCOM information please see www.biocom.org . BIOCOM/San Diego: 4940 Carroll Canyon Road, Suite B San Diego, CA 92121 Phone: 619/455-0300 Fax: 619/455-0022 ------------------------------------------------------------------------ NG/sd CONTACT: BIOCOM/San Diego, 619/455-0300 Web site: biocom.org KEYWORD: CALIFORNIA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL MEDICINE ADVISORY Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com